ω-3 Fatty Acid Supplements for Secondary Prevention of Cardiovascular Disease: From “No Proof of Effectiveness” to “Proof of No Effectiveness”

Page 1

	Year	Citations
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial The Lancet Vitamin ENutritionCardiovascular DiseaseOmega-3 Fatty AcidLipid Nutrition	1999	3.8K
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Mitsuhiro Yokoyama, Hideki Origasa, Masunori Matsuzaki, The Lancet Metabolic SyndromeHypercholesterolaemic PatientsCardiovascular DiseaseEndpoint AnalysisMedicine	2007	2.5K
Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis Jørn Wetterslev, Kristian Thorlund, Jesper Brok, Journal of Clinical Epidemiology Firm EvidenceMeta-analysisCumulative Meta-analysisBusinessRandomized Controlled Trial	2007	1.8K
Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses Jesper Brok, Kristian Thorlund, Christian Gluud, Journal of Clinical Epidemiology Many Meta-analysesMeta-analysisPsychiatryClinical StudiesClinical Trials	2008	1.1K

Page 1